XML 16 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2021
Dec. 31, 2020
Assets    
Cash and cash equivalents $ 34,323 [1] $ 40,348
Cash and investments segregated and on deposit for regulatory purposes (including resale agreements of $13,625 at September 30, 2021 and $14,904 at December 31, 2020) 42,300 50,399
Receivables from brokerage clients — net 86,553 64,440
Available for sale securities (amortized cost of $375,305 at September 30, 2021 and $330,248 at December 31, 2020) 376,968 337,400
Bank loans — net 31,570 23,813
Equipment, office facilities, and property — net 3,164 2,883
Goodwill 11,952 11,952
Acquired intangible assets — net 9,532 9,991
Other assets 11,186 7,783
Total assets 607,548 549,009
Liabilities and Stockholders’ Equity    
Bank deposits 395,275 358,022
Payables to brokerage clients 113,052 104,201
Accrued expenses and other liabilities 19,249 17,094
Short-term borrowings 3,000 0
Long-term debt 19,530 13,632
Total liabilities 550,106 492,949
Stockholders’ equity:    
Preferred stock — $.01 par value per share; aggregate liquidation preference of $10,100 and $7,850 at September 30, 2021 and December 31, 2020, respectively 9,954 7,733
Additional paid-in capital 26,755 26,515
Retained earnings 24,880 21,975
Treasury stock, at cost — 185,198,080 shares at September 30, 2021 and 193,577,648 shares at December 31, 2020 (5,421) (5,578)
Accumulated other comprehensive income (loss) 1,253 5,394
Total stockholders’ equity 57,442 56,060
Total liabilities and stockholders’ equity 607,548 549,009
Common Stock [Member]    
Stockholders’ equity:    
Common stock 20 20
Nonvoting Common Stock [Member]    
Stockholders’ equity:    
Common stock $ 1 $ 1
[1] For more information on the nature of restrictions on restricted cash and cash equivalents, see Note 17.